NCT00547248View on ClinicalTrials.gov

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

October 22, 2007

Primary Completion Date

May 10, 2008

Study Completion Date

October 7, 2008

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Synflorix

Intramuscular injection, 1 dose

BIOLOGICAL

Tritanrix-HepB

Intramuscular injection, 1 dose

BIOLOGICAL

Hiberix

Reconstituted with Tritanrix-Hep B before injection

BIOLOGICAL

Polio Sabin

Oral, 1 dose

BIOLOGICAL

Poliorix

Intramuscular injection, 1 dose

BIOLOGICAL

Prevenar (Wyeth)

Intramuscular injection, 1 dose

Trial Locations (7)

1781

GSK Investigational Site, City of Muntinlupa

50345

GSK Investigational Site, Wroclaw

80-394

GSK Investigational Site, Gdansk

91-347

GSK Investigational Site, Lodz

55-100

GSK Investigational Site, Trzebnica

89-500

GSK Investigational Site, Tuchola

52-312

GSK Investigational Site, Wroclaw

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00547248 - Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines | Biotech Hunter | Biotech Hunter